New York Assembly bill in Session 2025-2026.
Status: in_committee. Latest action: April 14, 2026.
Enhances transparency in the prescription drug supply chain.
Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
| Date | Event | Detail |
|---|---|---|
| 2026-04-14 | Introduced | Bill introduced |
| 2026-04-14 | Status | in_committee |
| 2026-04-14 | Latest Action | In Assembly Committee |